#$%^&*AU2017200565A120170223.pdf#####98 ABSTRACT By replacing the antigen-binding domain, the present inventors discovered novel polypeptide complexes that retain BiTE's strong anti-tumor activity and excellent safety 5 properties, as well as have long half-life in blood and can damage various different target cells.